Pharma Focus Asia

POINT Biopharma to Launch its First Manufacturing Facility in US

Introduction:

Canada-based clinical-stage biopharmaceutical company, POINT Biopharma (POINT) invests more than US$25 million to launch its first drug manufacturing facility in Indianapolis, US.

Features:

With an investment of more than US$25 million, the company will own and renovatethe current 77,000-square-foot, building in Indianapolis into an advanced facility compliant with Good Manufacturing Practices (GMP).

The new buildingcreates an opportunity to fasten drug manufacturing activities, planning to develop and distribute more than 400,000 dosesannually. In addition, the expansion includes custom equipment to further improve packaging and distribution capabilities by establishing clean-room manufacturing facilities.

The new manufacturing site enables patients globally by providing life-saving cancer treatments, allowing company to deliver its products to other coast markets quickly.

Initially, more than 30 Indiana-based employees are hired to speed up manufacturing activities.It is anticipated to open 100 new job opportunities, shaping the future of companyby the end of 2024.

The project is expected to relocate to its new location in the second half of 2020, while the facility to be completed and fully be operational by 2021.

Specifications:

NamePOINT Biopharma
TypeExpansion
Year2021
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?